Propanc Biopharma (PPCB) vs Revelation Biosciences (REVB)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Revelation Biosciences is the larger company by market cap ($2.0 million vs $1.9 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | PPCB | REVB |
|---|---|---|
| Share price | $1.78 | $3.50 |
| Market cap | $1.87M | $1.99M |
| 1-day change | +3.19% | -5.15% |
| EPS (TTM) | $-95.92 | $-99.96 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Net income (latest FY) | $-18.86M | $-8.91M |
| 52-week high | $315.00 | $40.60 |
| 52-week low | $1.61 | $3.08 |
| Distance from 52-week high | -99.43% | -91.38% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +407.14% |
| Average volume | 188.66K | 12.49K |
| Shares outstanding | 1.05M | 569.06K |
| Employees | 2 | 8 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Propanc Biopharma
PPCB stock →Propanc Biopharma, Inc., a development-stage biopharmaceutical healthcare company, engages in the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancers in Australia. Its lead product candidate is PRP, an intravenous injection proenzyme treatment designed as a therapeutic option in cancer treatment and prevention which has completed pre-clinical studies.
Health Care · Biotechnology: Pharmaceutical Preparations · 2 employees
About Revelation Biosciences
REVB stock →Revelation Biosciences, Inc. operates as a clinical-stage life science company that focuses on the rebalancing inflammation to optimize health.
Health Care · Biotechnology: Pharmaceutical Preparations · 8 employees
PPCB vs REVB FAQ
Which is bigger, Propanc Biopharma or Revelation Biosciences?
Revelation Biosciences (REVB) is larger, with a market capitalization of $1.99M compared with $1.87M for Propanc Biopharma (PPCB).
Are Propanc Biopharma and Revelation Biosciences in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.